Prescription drug application user fees will increase again in fiscal year 2025, although not as much as the previous year, while similar charges for generics and biosimilars will spike.
Key Takeaways
-
PDUFA, GDUFA and BsUFA application fees are set to increase again in FY 2025.
PDUFA fees for applications requiring clinical data will jump 6.5% to $4.31m in the upcoming fiscal year compared to FY...